Terms: = Lung cancer AND XPC, XP3, 7508, ENSG00000154767, XPCC AND Treatment
23 results:
1. Genetic Variants Associated With Response to Platinum-Based Chemotherapy in Non-Small Cell lung cancer Patients: A Field Synopsis and Meta-Analysis.
Sito H; Sharzehan MAK; Islam MA; Tan SC
Br J Biomed Sci; 2024; 81():11835. PubMed ID: 38450253
[No Abstract] [Full Text] [Related]
2. DNA Repair Capacity for Personalizing Risk and treatment Response - Assay Development and Optimization in Human Peripheral Blood Mononuclear Cells (PBMCs).
Nasrallah NA; Zhou H; Smith PA; Sears CR
DNA Repair (Amst); 2022 Mar; 111():103274. PubMed ID: 35085879
[TBL] [Abstract] [Full Text] [Related]
3. Downregulation of Xeroderma Pigmentosum Complementation Group C Expression by 17-Allylamino-17-Demethoxygeldanamycin Enhances Bevacizumab-Induced Cytotoxicity in Human lung cancer Cells.
Chen JC; Ko JC; Taso YC; Cheng HH; Chen TY; Yen TC; Lin YW
Pharmacology; 2021; 106(3-4):154-168. PubMed ID: 33202406
[TBL] [Abstract] [Full Text] [Related]
4. Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1α mediated xpc transcription.
Liu Y; Wang X; Li W; Xu Y; Zhuo Y; Li M; He Y; Wang X; Guo Q; Zhao L; Qiang L
Oncogene; 2020 Nov; 39(45):6893-6905. PubMed ID: 32978517
[TBL] [Abstract] [Full Text] [Related]
5. Genetic polymorphisms of GSTP1, XRCC1, xpc and ERCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer patients of Bangladesh.
Bushra MU; Rivu SF; Sifat AE; Nahid NA; Ahmed MU; Al-Mamun MMA; Apu MNH; Islam MS; Islam MR; Islam MS; Hasnat A
Mol Biol Rep; 2020 Sep; 47(9):7073-7082. PubMed ID: 32880833
[TBL] [Abstract] [Full Text] [Related]
6. DNA repair as an emerging target for COPD-lung cancer overlap.
Sears CR
Respir Investig; 2019 Mar; 57(2):111-121. PubMed ID: 30630751
[TBL] [Abstract] [Full Text] [Related]
7. xpc protects against smoking- and carcinogen-induced lung adenocarcinoma.
Zhou H; Saliba J; Sandusky GE; Sears CR
Carcinogenesis; 2019 May; 40(3):403-411. PubMed ID: 30624620
[TBL] [Abstract] [Full Text] [Related]
8. 17-(Allylamino)-17-Demethoxygeldanamycin Enhances Etoposide-Induced Cytotoxicity via the Downregulation of Xeroderma Pigmentosum Complementation Group C Expression in Human lung Squamous Cell Carcinoma Cells.
Chen JC; Ma PF; Lin YC; Wu CH; Peng YS; Zheng HY; Lin MC; Li YT; Lin YW
Pharmacology; 2018; 102(1-2):91-104. PubMed ID: 29953987
[TBL] [Abstract] [Full Text] [Related]
9. Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
Betti M; Casalone E; Ferrante D; Aspesi A; Morleo G; Biasi A; Sculco M; Mancuso G; Guarrera S; Righi L; Grosso F; Libener R; Pavesi M; Mariani N; Casadio C; Boldorini R; Mirabelli D; Pasini B; Magnani C; Matullo G; Dianzani I
Cancer Lett; 2017 Oct; 405():38-45. PubMed ID: 28687356
[TBL] [Abstract] [Full Text] [Related]
10. xpc Polymorphism and Risk for lung cancer in North Indian Patients Treated with Platinum Based Chemotherapy and Its Association with Clinical Outcomes.
Lawania S; Singh N; Behera D; Sharma S
Pathol Oncol Res; 2018 Apr; 24(2):353-366. PubMed ID: 28540485
[TBL] [Abstract] [Full Text] [Related]
11. Inorganic arsenic inhibits the nucleotide excision repair pathway and reduces the expression of xpc.
Holcomb N; Goswami M; Han SG; Scott T; D'Orazio J; Orren DK; Gairola CG; Mellon I
DNA Repair (Amst); 2017 Apr; 52():70-80. PubMed ID: 28237621
[TBL] [Abstract] [Full Text] [Related]
12. Exposure of Human lung Cells to Tobacco Smoke Condensate Inhibits the Nucleotide Excision Repair Pathway.
Holcomb N; Goswami M; Han SG; Clark S; Orren DK; Gairola CG; Mellon I
PLoS One; 2016; 11(7):e0158858. PubMed ID: 27391141
[TBL] [Abstract] [Full Text] [Related]
13. The study of the relation of DNA repair pathway genes SNPs and the sensitivity to radiotherapy and chemotherapy of NSCLC.
Wang C; Nie H; Li Y; Liu G; Wang X; Xing S; Zhang L; Chen X; Chen Y; Li Y
Sci Rep; 2016 Jun; 6():26526. PubMed ID: 27246533
[TBL] [Abstract] [Full Text] [Related]
14. The Effects of Residential Segregation and Neighborhood Characteristics on Surgery and Survival in Patients with Early-Stage Non-Small Cell lung cancer.
Johnson AM; Johnson A; Hines RB; Bayakly R
Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):750-8. PubMed ID: 27197137
[TBL] [Abstract] [Full Text] [Related]
15. Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with "Ultracentral" Non-Small Cell lung cancer.
Tekatli H; Haasbeek N; Dahele M; De Haan P; Verbakel W; Bongers E; Hashemi S; Nossent E; Spoelstra F; de Langen AJ; Slotman B; Senan S
J Thorac Oncol; 2016 Jul; 11(7):1081-9. PubMed ID: 27013408
[TBL] [Abstract] [Full Text] [Related]
16. The relationship between polymorphisms of genes regulating DNA repair or cell division and the toxicity of platinum and vinorelbine chemotherapy in advanced NSCLC patients.
Powrózek T; Mlak R; Krawczyk P; Homa I; Ciesielka M; Kozioł P; Prendecka M; Milanowski J; Małecka-Massalska T
Clin Transl Oncol; 2016 Feb; 18(2):125-31. PubMed ID: 26193985
[TBL] [Abstract] [Full Text] [Related]
17. Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer.
Liu L; Wu J; Zhong R; Wu C; Zou L; Yang B; Chen W; Zhu B; Duan S; Yu D; Tan W; Nie S; Lin D; Miao X
Mol Carcinog; 2013 Dec; 52(12):923-31. PubMed ID: 22821704
[TBL] [Abstract] [Full Text] [Related]
18. xpc Lys939Gln polymorphism is associated with the decreased response to platinum based chemotherapy in advanced non-small-cell lung cancer.
Zhu XL; Sun XC; Chen BA; Sun N; Cheng HY; Li F; Zhang HM; Feng JF; Qin SK; Cheng L; Lu ZH
Chin Med J (Engl); 2010 Dec; 123(23):3427-32. PubMed ID: 22166526
[TBL] [Abstract] [Full Text] [Related]
19. Cisplatin transiently up-regulates hHR23 expression through enhanced translational efficiency in A549 adenocarcinoma cells.
Shen YH; Chen BR; Cherng SH; Chueh PJ; Tan X; Lin YW; Lin JC; Chuang SM
Toxicol Lett; 2011 Sep; 205(3):341-50. PubMed ID: 21742020
[TBL] [Abstract] [Full Text] [Related]
20. xpc gene intron 11 C/A polymorphism is a predictive biomarker for the sensitivity to NP chemotherapy in patients with non-small cell lung cancer.
Zhu LB; Xu Q; Hong CY; Yue Z; Zhang Y; Ye HN; Yuan Y
Anticancer Drugs; 2010 Aug; 21(7):669-73. PubMed ID: 20571354
[TBL] [Abstract] [Full Text] [Related]
[Next]
